Incremental Shuttle Walk Test predicts survival in non-Group 1 Pulmonary Hypertension without a ceiling effect
C. Billings (Sheffield, United Kingdom), R. Lewis (Sheffield, United Kingdom), J. Hurdman (Sheffield, United Kingdom), I. Armstrong (Sheffield, United Kingdom), I. Smith (Sheffield, United Kingdom), M. Austin (Sheffield, United Kingdom), C. Elliot (Sheffield, United Kingdom), A. Charalampopoulos (Sheffield, United Kingdom), I. Sabroe (Sheffield, United Kingdom), A. Lawrie (Sheffield, United Kingdom), R. Thompson (Sheffield, United Kingdom), R. Condliffe (Sheffield, United Kingdom), D. Kiely (Sheffield, United Kingdom)
Source: International Congress 2018 – Pulmonary hypertension: right ventricle function, haemodynamics and exercise
Disease area: Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Billings (Sheffield, United Kingdom), R. Lewis (Sheffield, United Kingdom), J. Hurdman (Sheffield, United Kingdom), I. Armstrong (Sheffield, United Kingdom), I. Smith (Sheffield, United Kingdom), M. Austin (Sheffield, United Kingdom), C. Elliot (Sheffield, United Kingdom), A. Charalampopoulos (Sheffield, United Kingdom), I. Sabroe (Sheffield, United Kingdom), A. Lawrie (Sheffield, United Kingdom), R. Thompson (Sheffield, United Kingdom), R. Condliffe (Sheffield, United Kingdom), D. Kiely (Sheffield, United Kingdom). Incremental Shuttle Walk Test predicts survival in non-Group 1 Pulmonary Hypertension without a ceiling effect. 3322
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: